Bristol-Myers Squibb Company
273 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Browse all held record sources
Zoom to read. Drag to explore. Select a connection.
Every link on this map
The same connections as a table, with the reason each one is here.
| HR 1 | Bills it lobbied on | Bristol-Myers Squibb Company named HR 1, “An act to provide for reconciliation pursuant to title II of H. Con. Res. 14”, in 10 lobbying reports. | 10 reports |
| HR 4299 | Bills it lobbied on | Bristol-Myers Squibb Company named HR 4299, “Protecting Patient Access to Cancer and Complex Therapies Act”, in 8 lobbying reports. | 8 reports |
| HR 1492 | Bills it lobbied on | Bristol-Myers Squibb Company named HR 1492, “To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program”, in 8 lobbying reports. | 8 reports |
| HR 7635 | Bills it lobbied on | Bristol-Myers Squibb Company named HR 7635, “CHARGE Act”, in 8 lobbying reports. | 8 reports |
| AB 36 | Bills it lobbied on | Bristol-Myers Squibb Company named AB 36, “Confidentiality of writings”, in 7 lobbying reports. | 7 reports |
| S 864 | Bills it lobbied on | Bristol-Myers Squibb Company named S 864, “HELP Copays Act”, in 7 lobbying reports. | 7 reports |
| S 1339 | Bills it lobbied on | Bristol-Myers Squibb Company named S 1339, “Stop CCP Money Laundering Act of 2025”, in 6 lobbying reports. | 6 reports |
| SB 1307 | Bills it lobbied on | Bristol-Myers Squibb Company named SB 1307, “Pharmacy: pedigree”, in 5 lobbying reports. | 5 reports |
| HR 830 | Bills it lobbied on | Bristol-Myers Squibb Company named HR 830, “SAFE Act”, in 5 lobbying reports. | 5 reports |
| HR 1968 | Bills it lobbied on | Bristol-Myers Squibb Company named HR 1968, “Full-Year Continuing Appropriations and Extensions Act, 2025”, in 5 lobbying reports. | 5 reports |
| HR 3285 | Bills it lobbied on | Bristol-Myers Squibb Company named HR 3285, “Student Loan Marriage Penalty Elimination Act of 2025”, in 4 lobbying reports. | 4 reports |
| AB 45 | Bills it lobbied on | Bristol-Myers Squibb Company named AB 45, “Household hazardous waste”, in 4 lobbying reports. | 4 reports |
| AB 347 | Bills it lobbied on | Bristol-Myers Squibb Company named AB 347, “Health care coverage: step therapy”, in 4 lobbying reports. | 4 reports |
| S 891 | Bills it lobbied on | Bristol-Myers Squibb Company named S 891, “Bipartisan Health Care Act”, in 4 lobbying reports. | 4 reports |
| S 526 | Bills it lobbied on | Bristol-Myers Squibb Company named S 526, “Pharmacy Benefit Manager Transparency Act of 2025”, in 4 lobbying reports. | 4 reports |
| HR 3521 | Bills it lobbied on | Bristol-Myers Squibb Company named HR 3521, “Clinical Trial Modernization Act”, in 4 lobbying reports. | 4 reports |
| SB 598 | Bills it lobbied on | Bristol-Myers Squibb Company named SB 598, “Biosimilars”, in 3 lobbying reports. | 3 reports |
| SB 786 | Bills it lobbied on | Bristol-Myers Squibb Company named SB 786, “Prescription drug pricing”, in 3 lobbying reports. | 3 reports |
| AB 1460 | Bills it lobbied on | Bristol-Myers Squibb Company named AB 1460, “Prescription drug pricing”, in 3 lobbying reports. | 3 reports |
| SB 966 | Bills it lobbied on | Bristol-Myers Squibb Company named SB 966, “Pharmacy benefits”, in 3 lobbying reports. | 3 reports |
| AB 463 | Bills it lobbied on | Bristol-Myers Squibb Company named AB 463, “Pharmaceutical Cost Transparency Act of 2016”, in 3 lobbying reports. | 3 reports |
| SB 1361 | Bills it lobbied on | Bristol-Myers Squibb Company named SB 1361, “Prescription drugs: cost sharing: pharmacy benefit managers”, in 3 lobbying reports. | 3 reports |
| SB 671 | Bills it lobbied on | Bristol-Myers Squibb Company named SB 671, “Pharmacy: biological product”, in 3 lobbying reports. | 3 reports |
| AB 283 | Bills it lobbied on | Bristol-Myers Squibb Company named AB 283, “Solid waste: extended producer responsibility program”, in 3 lobbying reports. | 3 reports |
| AB 2911 | Bills it lobbied on | Bristol-Myers Squibb Company named AB 2911, “Oil spill prevention and response: inland spills: wildlife contaminations”, in 3 lobbying reports. | 3 reports |
| SB 493 | Bills it lobbied on | Bristol-Myers Squibb Company named SB 493, “Pharmacy practice”, in 3 lobbying reports. | 3 reports |
| SB 1010 | Bills it lobbied on | Bristol-Myers Squibb Company named SB 1010, “Health care: prescription drug costs”, in 3 lobbying reports. | 3 reports |
| SB 939 | Bills it lobbied on | Bristol-Myers Squibb Company named SB 939, “Prescription drug pricing”, in 3 lobbying reports. | 3 reports |
| SB 496 | Bills it lobbied on | Bristol-Myers Squibb Company named SB 496, “Biomarker testing”, in 3 lobbying reports. | 3 reports |
| HR 3283 | Bills it lobbied on | Bristol-Myers Squibb Company named HR 3283, “FARMER Act”, in 2 lobbying reports. | 2 reports |
| S 2973 | Bills it lobbied on | Bristol-Myers Squibb Company named S 2973, “SHUTDOWN Act”, in 2 lobbying reports. | 2 reports |
| AB 103 | Bills it lobbied on | Bristol-Myers Squibb Company named AB 103, “Pharmaceuticals: marketing activities”, in 2 lobbying reports. | 2 reports |
| SB 17 | Bills it lobbied on | Bristol-Myers Squibb Company named SB 17, “Health care: prescription drug costs”, in 2 lobbying reports. | 2 reports |
| AB 265 | Bills it lobbied on | Bristol-Myers Squibb Company named AB 265, “Prescription drugs: prohibition on price discount”, in 2 lobbying reports. | 2 reports |
| SB 1346 | Bills it lobbied on | Bristol-Myers Squibb Company named SB 1346, “Surplus medication collection and distribution”, in 2 lobbying reports. | 2 reports |
| SB 26 | Bills it lobbied on | Bristol-Myers Squibb Company named SB 26, “Hazardous waste: household hazardous waste collection facility: small quantity generators”, in 2 lobbying reports. | 2 reports |
| SB 797 | Bills it lobbied on | Bristol-Myers Squibb Company named SB 797, “Product safety: bisphenol A”, in 2 lobbying reports. | 2 reports |
| HR 5509 | Bills it lobbied on | Bristol-Myers Squibb Company named HR 5509, “Safe Step Act”, in 2 lobbying reports. | 2 reports |
| AB 1587 | Bills it lobbied on | Bristol-Myers Squibb Company named AB 1587, “Personal information: pharmacy”, in 2 lobbying reports. | 2 reports |
| HR 5378 | Bills it lobbied on | Bristol-Myers Squibb Company named HR 5378, “Tribal Healthcare Careers Act”, in 2 lobbying reports. | 2 reports |
| S 127 | Bills it lobbied on | Bristol-Myers Squibb Company named S 127, “Whole-Home Repairs Act of 2025”, in 2 lobbying reports. | 2 reports |
| AB 73 | Bills it lobbied on | Bristol-Myers Squibb Company named AB 73, “Real property: disclosure”, in 2 lobbying reports. | 2 reports |
| HR 7391 | Bills it lobbied on | Bristol-Myers Squibb Company named HR 7391, “Community Health Center Drug Pricing Protection Act”, in 2 lobbying reports. | 2 reports |
| AB 2690 | Bills it lobbied on | Bristol-Myers Squibb Company named AB 2690, “Product liability actions: prescription pharmaceutical products”, in 2 lobbying reports. | 2 reports |
| AB 1159 | Bills it lobbied on | Bristol-Myers Squibb Company named AB 1159, “Product stewardship: pilot program: household batteries and home-generated sharps waste”, in 2 lobbying reports. | 2 reports |
| HR 8412 | Bills it lobbied on | Bristol-Myers Squibb Company named HR 8412, “To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to revise certain regulations related to infant and toddler beverages, and for other purposes”, in 2 lobbying reports. | 2 reports |
| AB 2752 | Bills it lobbied on | Bristol-Myers Squibb Company named AB 2752, “Health care coverage: continuity of care”, in 2 lobbying reports. | 2 reports |
| SB 212 | Bills it lobbied on | Bristol-Myers Squibb Company named SB 212, “Solid waste: pharmaceutical and sharps waste stewardship”, in 1 lobbying report. | 1 report |
| SB 951 | Bills it lobbied on | Bristol-Myers Squibb Company named SB 951, “Health care coverage: essential health benefits”, in 1 lobbying report. | 1 report |
| SB 208 | Bills it lobbied on | Bristol-Myers Squibb Company named SB 208, “Medi-Cal”, in 1 lobbying report. | 1 report |
Showing 50 of 273
In the news
Reporting about the selected subject. Articles are context and do not establish a connection on this map.
Loading coverage…
